{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:07Z","timestamp":1790634847127,"version":"4.1.0"},"reference-count":26,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec><jats:title>Background\/Aims<\/jats:title><jats:p>To compare the efficacy, anatomical outcomes and complications of intravitreal ranibizumab with those of laser photocoagulation for retinopathy of prematurity (ROP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective case series of 314 eyes from 165 infants diagnosed with type I ROP and treated with either laser photocoagulation (161 eyes) or intravitreal ranibizumab (0.25 mg\/0.025 mL) injection (153 eyes) between January 2006 and December 2016 in a tertiary referral-based hospital. The main outcome was the rate of recurrence requiring additional treatment. Secondary outcomes included the incidence of major complications and final refractive error.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean follow-up was 36.3\u00b131.9 months. Recurrences requiring further intervention were noted in 22 (13.7%) laser-treated and 15 (9.8%) ranibizumab-treated eyes (p=0.196). Retinal detachment (8 vs 1, p=0.037) and macular dragging (7 vs 1, p=0.039) were observed in the laser-treated and injection-treated groups, respectively, but no systemic or neurodevelopmental adverse events were reported. In the ranibizumab group, 95.6% showed fully vascularised retinas. Multivariate analyses revealed that birth weight (OR 0.993, p=0.023) and higher ROP stage (OR 11.222, p=0.008) influenced the incidence of major complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intravitreal ranibizumab for ROP appears to achieve similar therapeutic effects than did laser photocoagulation, but with fewer surgical complications such as retinal detachment or macular dragging.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2018-312272","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T22:25:12Z","timestamp":1543962312000},"page":"1332-1336","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety"],"prefix":"10.1136","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8359-9618","authenticated-orcid":false,"given":"Hyun Goo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Ho","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Jun","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-6959","authenticated-orcid":false,"given":"Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"2020050713050026000_103.9.1332.1","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.205"},{"key":"2020050713050026000_103.9.1332.2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1977.04450010031002"},{"key":"2020050713050026000_103.9.1332.3","unstructured":"Malcolm W . Beyond the NICU: comprehensive care of the high-risk infant. Mcgraw hill professional, 2014."},{"key":"2020050713050026000_103.9.1332.4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/jpc.12860","article-title":"Retinopathy of prematurity: new developments bring concern and hope","volume":"51","author":"Darlow","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"2020050713050026000_103.9.1332.5","first-page":"233","article-title":"Final results of the early treatment for retinopathy of prematurity (etrop) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2020050713050026000_103.9.1332.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007374"},{"key":"2020050713050026000_103.9.1332.7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2020050713050026000_103.9.1332.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3218"},{"key":"2020050713050026000_103.9.1332.9","doi-asserted-by":"crossref","unstructured":"Yonekawa Y , WC W , Nitulescu CE , et al . Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab. Retina 2017.","DOI":"10.1097\/IAE.0000000000001685"},{"key":"2020050713050026000_103.9.1332.10","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3892\/etm.2017.4406","article-title":"Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: a case report","volume":"13","author":"Wang","year":"2017","journal-title":"Exp Ther Med"},{"key":"2020050713050026000_103.9.1332.11","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.3928\/19382359-20171023-02","article-title":"Hot topics in retinopathy of prematurity","volume":"46","author":"Tsui","year":"2017","journal-title":"Pediatr Ann"},{"key":"2020050713050026000_103.9.1332.12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ophtha.2017.03.018","article-title":"Ranibizumab injection as primary treatment in patients with retinopathy of prematurity: anatomic outcomes and influencing factors","volume":"124","author":"Huang","year":"2017","journal-title":"Ophthalmology"},{"key":"2020050713050026000_103.9.1332.13","doi-asserted-by":"crossref","unstructured":"Semeraro F , Morescalchi F , Duse S , et al . Aflibercept in wet AMD: specific role and optimal use. Drug Des Devel Ther 2013;7:711.doi:10.2147\/DDDT.S40215","DOI":"10.2147\/DDDT.S40215"},{"key":"2020050713050026000_103.9.1332.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000242842.14624.e7"},{"key":"2020050713050026000_103.9.1332.15","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.991"},{"issue":"Suppl 1","key":"2020050713050026000_103.9.1332.16","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.3346\/jkms.2015.30.S1.S88","article-title":"Retinopathy of prematurity among very-low-birth-weight infants in korea: incidence, treatment, and risk factors","volume":"30","author":"Hwang","year":"2015","journal-title":"J Korean Med Sci"},{"key":"2020050713050026000_103.9.1332.17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3341\/kjo.2012.26.4.277","article-title":"Long-term results of lens-sparing vitrectomy for progressive posterior-type stage 4A retinopathy of prematurity","volume":"26","author":"Choi","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"2020050713050026000_103.9.1332.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208129"},{"key":"2020050713050026000_103.9.1332.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.05.031"},{"key":"2020050713050026000_103.9.1332.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2014.08.011"},{"key":"2020050713050026000_103.9.1332.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302276"},{"key":"2020050713050026000_103.9.1332.22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","article-title":"An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan","volume":"155","author":"Wu","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"2020050713050026000_103.9.1332.23","first-page":"6","article-title":"Effects of ranibizumab in zone I and zone II retinopathy of prematurity patients","volume":"31","author":"Chen","year":"2015","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"2020050713050026000_103.9.1332.24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","article-title":"Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone i","volume":"37","author":"Yoon","year":"2017","journal-title":"Retina"},{"key":"2020050713050026000_103.9.1332.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00695-9"},{"key":"2020050713050026000_103.9.1332.26","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.ophtha.2016.04.024","article-title":"Does bevacizumab alter vascularization potential in retinopathy of prematurity?","volume":"123","author":"Isaac","year":"2016","journal-title":"Ophthalmology"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-312272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:57:52Z","timestamp":1601110672000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-312272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,8,23]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bjophthalmol-2018-312272"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312272","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]}}}